In recent extraordinary moves, Health Secretary Robert F. Kennedy Jr. has fired and replaced a team that makes vaccine recommendations for the country. Apoorva Mandavilli, a science and global health reporter at The New York Times, explains how this change could impact vaccine accessibility. Source link #Video #Vaccines #Arent #Recommended
Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of Health said Monday, opening enrollment for the first of an array of federally-funded studies aimed at evaluating treatments for long-term symptoms still faced by many COVID-19 survivors. They will begin with a study into using … Read more
News Release Tuesday, October 4, 2022 The 2022 NIH Director’s Awards enable exceptionally creative scientists to push the boundaries of biomedical science. The High-Risk, High-Reward Research program, supported by the Common Fund at the National Institutes of Health has awarded 103 new research grants to support highly innovative scientists who propose visionary … Read more
Media Advisory Monday, September 12, 2022 NIH-funded results add to growing scientific evidence of negative health effects of cannabis use during pregnancy What Prenatal cannabis exposure following the middle of the first trimester—generally after five to six weeks of fetal development—is associated with attention, social, and behavioral problems that persist as the affected children … Read more
Media Advisory Wednesday, August 31, 2022 What: At the National Institutes of Health, a surgical team successfully implanted a patch of tissue made from patient cells with the goal of treating advanced “dry” age-related macular degeneration (AMD), also known as geographic atrophy. Dry AMD is a leading cause of vision loss among older Americans and … Read more
Media Advisory Monday, August 29, 2022 What The amount of SARS-CoV-2 antigen measured in the blood of patients hospitalized with COVID-19 is associated with illness severity and other clinical outcomes, according to a new study published in the Annals of Internal Medicine. Following the ACTIV-3 trial of COVID-19 therapeutics in people hospitalized with COVID-19, researchers … Read more